These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32752563)

  • 21. Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection.
    Oxman MN; Gershon AA; Poland GA
    Vaccine; 2011 May; 29(20):3625-7. PubMed ID: 21524565
    [No Abstract]   [Full Text] [Related]  

  • 22. Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases.
    Benedict Kpozehouen E; Macintyre CR; Tan TC
    Vaccine; 2024 May; 42(15):3404-3409. PubMed ID: 38704255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Multifaceted Intervention to Improve Influenza, Pneumococcal, and Herpes Zoster Vaccination among Patients with Rheumatoid Arthritis.
    Baker DW; Brown T; Lee JY; Ozanich A; Liss DT; Sandler DS; Ruderman EM
    J Rheumatol; 2016 Jun; 43(6):1030-7. PubMed ID: 27084914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varicella zoster virus redux.
    Gelb LD
    Herpes; 2009 Jan; 15(3):62-3. PubMed ID: 19306605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(40):816-9. PubMed ID: 23051612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The intention of Dutch general practitioners to offer vaccination against pneumococcal disease, herpes zoster and pertussis to people aged 60 years and older.
    Lehmann BA; Eilers R; Mollema L; Ferreira J; de Melker HE
    BMC Geriatr; 2017 Jun; 17(1):122. PubMed ID: 28592229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimated Human and Economic Burden of Four Major Adult Vaccine-Preventable Diseases in the United States, 2013.
    McLaughlin JM; McGinnis JJ; Tan L; Mercatante A; Fortuna J
    J Prim Prev; 2015 Aug; 36(4):259-73. PubMed ID: 26032932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations.
    Prosser LA; Harpaz R; Rose AM; Gebremariam A; Guo A; Ortega-Sanchez IR; Zhou F; Dooling K
    Ann Intern Med; 2019 Mar; 170(6):380-388. PubMed ID: 30776797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant administration of pneumococcal-23 and zoster vaccines provides adequate herpes zoster coverage.
    Wyman MJ; Stabi KL
    Ann Pharmacother; 2013; 47(7-8):1064-8. PubMed ID: 23715069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children - Advisory Committee on Immunization Practices (ACIP), 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):258-61. PubMed ID: 20224542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine responsiveness in the elderly: best practice for the clinic.
    Aspinall R; Lang PO
    Expert Rev Vaccines; 2014 Jul; 13(7):885-94. PubMed ID: 24890875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why should older adults receive the shingles vaccine?
    Harkness TL
    J Gerontol Nurs; 2010 Oct; 36(10):51-5. PubMed ID: 20506935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination coverage and predictors of influenza, pneumococcal, herpes zoster, tetanus, measles, and hepatitis B vaccine uptake among adults in Greece.
    Tsiligianni I; Bouloukaki I; Papazisis G; Paganas A; Chatzimanolis E; Kalatharas M; Platakis I; Tirodimos I; Dardavesis T; Tsimtsiou Z
    Public Health; 2023 Nov; 224():195-202. PubMed ID: 37820537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zoster vaccine live.
    Kockler DR; McCarthy MW
    Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Practical points for applying herpes zoster vaccine recommendations.
    Brogie JD; Rumph JH; Chaplin MD; Drake N; Hodge BK; Owens RE
    Nurse Pract; 2019 Sep; 44(9):43-47. PubMed ID: 31436592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review.
    Addario A; Célarier T; Bongue B; Barth N; Gavazzi G; Botelho-Nevers E
    Geroscience; 2023 Dec; 45(6):3419-3447. PubMed ID: 37269492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings: Recommendations From AMDA's Infection Advisory Committee.
    Nace DA; Archbald-Pannone LR; Ashraf MS; Drinka PJ; Frentzel E; Gaur S; Mahajan D; Mehr DR; Mercer WC; Sloane PD; Jump RL;
    J Am Med Dir Assoc; 2017 Feb; 18(2):99-104. PubMed ID: 28126142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Apr; 46(RR-8):1-24. PubMed ID: 9132580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
    Doan HQ; Ung B; Ramirez-Fort MK; Khan F; Tyring SK
    Expert Opin Biol Ther; 2013 Oct; 13(10):1467-77. PubMed ID: 23984934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on vaccine-preventable diseases: are adults in your community adequately protected?
    Schaffner W
    J Fam Pract; 2008 Apr; 57(4 Suppl):S1-11; quiz S12. PubMed ID: 18655764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.